Products for Research Use Only
RegisterLogin

Tozorakimab

CAT: 0804-HY-P99550-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99550-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease[1].
CAS Number
2376858-66-9
Product Name Alternative
MEDI-3506
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tozorakimab.html
Purity
98.82
Solubility
H2O
Smiles
[Tozorakimab]
Molecular Weight
(144.66 kDa)
References & Citations
[1]Reid F, et al. Safety, pharmacokinetics and immunogenicity of the anti-interleukin-33 antibody, tozorakimab: results of a phase 1 study in healthy adults and patients with chronic obstructive pulmonary disease. American Thoracic Society. 2022: A2398-A2398. |[2]England E, et al. Tozorakimab (MEDI3506) : an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction. Sci Rep. 2023 Jun 17;13 (1) :9825.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
82868-1Tozorakimab
GTR18337797-01Tozorakimab Antibody
HF543046-01Research Grade Tozorakimab
592273IL33, Tozorakimab Biosimilar
E55B0792Tozorakimab (Reference antibody)
21-979Tozorakimab - Research Grade Biosimilar
A3085-01Tozorakimab (Anti-IL-33)
047667IL-33 (tozorakimab) discontinued
A138595Tozorakimab Biosimilar (Monoclonal, IgG1)
ICH5938-5mgTozorakimab Biosimilar - Research Grade

Popular Products